Tandem Diabetes Care (TNDM) Stock Forecast & Price Target

→ REVEALED: Elon Musk’s Secret A.I. Facility? (From InvestorPlace) (Ad)

$31.86

-1.64 (-4.90%)

(As of 04/15/2024 ET)

Tandem Diabetes Care Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 12 Analyst Ratings

Analysts' Consensus Price Target

$37.00
16.13% Upside

High Forecast	$62.00
Average Forecast	$37.00
Low Forecast	$21.00

Type	Current Forecast 4/17/23 to 4/16/24	1 Month Ago 3/18/23 to 3/17/24	3 Months Ago 1/17/23 to 1/17/24	1 Year Ago 4/17/22 to 4/17/23
Consensus Rating	Hold	Hold	Hold	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	4 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)
Hold	6 Hold rating(s)	8 Hold rating(s)	8 Hold rating(s)	5 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$37.00	$36.00	$38.50	$61.77
Predicted Upside	16.13% Upside	27.11% Upside	29.83% Upside	38.35% Upside

Get Tandem Diabetes Care Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter.

Ad InvestorPlace

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

>>Check out what this A.I. Perfect Storm is<<

TNDM Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TNDM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Tandem Diabetes Care Stock vs. The Competition

Type	Tandem Diabetes Care	Medical Companies	S&P 500
Consensus Rating Score	2.33	2.68	2.48
Consensus Rating	Hold	Moderate Buy	Hold
Predicted Upside	16.13% Upside	882.68% Upside	11.24% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/3/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$31.00 ➝ $38.00	+10.21%
3/26/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$24.00 ➝ $37.00	+22.92%
11/2/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$40.00 ➝ $25.00	+64.47%
10/16/2023	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Kratky Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform
10/16/2023	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Market Perform	$21.00	+21.88%
10/2/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$47.00 ➝ $45.00	+116.66%
8/21/2023	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$33.00 ➝ $32.00	+9.70%
8/4/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$71.00 ➝ $62.00	+85.57%
8/4/2023	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$52.00 ➝ $34.00	+2.87%
8/4/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$40.00 ➝ $30.00	-7.44%
6/13/2023	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$74.00 ➝ $50.00	+93.12%
5/5/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Neutral ➝ Underperform	$45.00 ➝ $33.00	-12.02%
4/24/2023	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 07:27 AM ET.

TNDM Price Target - Frequently Asked Questions

What is Tandem Diabetes Care's consensus rating and price target?: According to the issued ratings of 12 analysts in the last year, the consensus rating for Tandem Diabetes Care stock is Hold based on the current 1 sell rating, 6 hold ratings and 5 buy ratings for TNDM. The average twelve-month price prediction for Tandem Diabetes Care is $37.00 with a high price target of $62.00 and a low price target of $21.00. Learn more on TNDM's analyst rating history.
Do Wall Street analysts like Tandem Diabetes Care more than its competitors?: Analysts like Tandem Diabetes Care less than other Medical companies. The consensus rating for Tandem Diabetes Care is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how TNDM compares to other companies.
Is Tandem Diabetes Care being upgraded by Wall Street analysts?: Over the previous 90 days, Tandem Diabetes Care's stock had 1 upgrade by analysts.

Does Tandem Diabetes Care's stock price have much upside?: According to analysts, Tandem Diabetes Care's stock has a predicted upside of 31.13% based on their 12-month stock forecasts.
What analysts cover Tandem Diabetes Care?: Tandem Diabetes Care has been rated by Citigroup, and Stifel Nicolaus in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NASDAQ:TNDM) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Tandem Diabetes Care (TNDM) Stock Forecast & Price Target

Tandem Diabetes Care Consensus Analyst Rating and Stock Price Forecast (2024)

Analysts' Consensus Rating

Analysts' Consensus Price Target

TNDM Analyst Ratings By Month

TNDM Price Targets by Month

Tandem Diabetes Care Stock vs. The Competition

Recent Analyst Ratings and Stock Forecasts

TNDM Price Target - Frequently Asked Questions

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info